These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3503686)

  • 21. Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.
    Splinter MY
    Ann Pharmacother; 2007 Feb; 41(2):285-95. PubMed ID: 17213296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K; Lyons KE
    Pharmacotherapy; 2009 Dec; 29(12):1452-67. PubMed ID: 19947805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restless legs syndrome/Willis-Ekbom disease in type 2 diabetes as the initial manifestation of Parkinson's disease and major cardiovascular disease.
    Hsu CH; Yu SM; Lau SC; Chen YL; Pei D; Liu IC
    Psychogeriatrics; 2017 Nov; 17(6):498-499. PubMed ID: 28332327
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduced regional activity and functional connectivity within sensorimotor network in Parkinson's patients with restless legs syndrome.
    Li Z; Chen J; Lin Y; Zhou M; Cai Q; Li X; Wu Z; Chen X; Yang X; Zhu X; Lu J; Zhang L; Liu B; Luo X; Xu P
    Mol Pain; 2019; 15():1744806919882272. PubMed ID: 31554460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to opioids in three patients with restless legs syndrome.
    Trzepacz PT; Violette EJ; Sateia MJ
    Am J Psychiatry; 1984 Aug; 141(8):993-5. PubMed ID: 6087688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease.
    Poewe W; Högl B
    Neurology; 2004 Oct; 63(8 Suppl 3):S12-6. PubMed ID: 15505135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
    Paulus W; Trenkwalder C
    Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism.
    Montplaisir J; Lorrain D; Godbout R
    Eur Neurol; 1991; 31(1):41-3. PubMed ID: 2015836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonazepam and vibration in restless legs syndrome.
    Montagna P; Sassoli de Bianchi L; Zucconi M; Cirignotta F; Lugaresi E
    Acta Neurol Scand; 1984 Jun; 69(6):428-30. PubMed ID: 6380197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of leg restlessness in Parkinson's disease compared with idiopathic Restless Legs Syndrome.
    Zhu XY; Liu Y; Zhang XJ; Yang WH; Feng Y; Ondo WG; Tan EK; Wu YC
    J Neurol Sci; 2015 Oct; 357(1-2):109-14. PubMed ID: 26189051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.
    Reuter I; Ellis CM; Ray Chaudhuri K
    Acta Neurol Scand; 1999 Sep; 100(3):163-7. PubMed ID: 10478579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No association between neuropathy and restless legs in Parkinson's disease.
    Rajabally YA; Martey J
    Acta Neurol Scand; 2013 Mar; 127(3):216-20. PubMed ID: 22989006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ropinirole in the treatment of restless legs syndrome.
    Kakar RS; Kushida CA
    Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation.
    Driver-Dunckley E; Evidente VG; Adler CH; Hillman R; Hernandez J; Fletcher G; Lyons MK
    Mov Disord; 2006 Aug; 21(8):1287-9. PubMed ID: 16671093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Problems associated with advancing Parkinson's disease].
    Nakashima K; Nomura T; Yasui K; Kitayama M; Nakaso K; Inoue Y
    Nihon Ronen Igakkai Zasshi; 2005 Sep; 42(5):529-31. PubMed ID: 16248414
    [No Abstract]   [Full Text] [Related]  

  • 36. Dopaminergic treatment of restless legs and rebound phenomenon.
    Guilleminault C; Cetel M; Philip P
    Neurology; 1993 Feb; 43(2):445. PubMed ID: 8094897
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?
    Paulus W; Schomburg ED
    Sleep Med Rev; 2006 Jun; 10(3):185-96. PubMed ID: 16762808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study.
    Montplaisir J; Godbout R; Boghen D; DeChamplain J; Young SN; Lapierre G
    Neurology; 1985 Jan; 35(1):130-4. PubMed ID: 3965987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients.
    Liguori C; Mercuri NB; Stefani A; Pierantozzi M
    Sleep Med; 2018 Jan; 41():113-114. PubMed ID: 29268951
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of restless legs syndrome, pain, and mood disorders in Parkinson's disease.
    Rana AQ; Qureshi AR; Rahman L; Jesudasan A; Hafez KK; Rana MA
    Int J Neurosci; 2016; 126(2):116-20. PubMed ID: 25469455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.